FC
ALNY icon

FIC Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History

FIC Capital’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$17.7M Sell
150,676
-19,653
-12% -$1.68M 6.75% 2
2017
Q2 		$13.6M Sell
170,329
-1,783
-1% -$114K 5.59% 2
2017
Q1 		$8.82M Sell
172,112
-130
-0.1% -$6.01K 3.91% 4
2016
Q4 		$6.45M Buy
172,242
+4,902
+3% +$205K 3.25% 4
2016
Q3 		$11.3M Sell
167,340
-2,208
-1% -$156K 5.09% 2
2016
Q2 		$9.41M Buy
169,548
+410
+0.2% +$25.8K 4.45% 2
2016
Q1 		$10.6M Buy
169,138
+4,432
+3% +$295K 5.14% 2
2015
Q4 		$15.5M Buy
164,706
+2,589
+2% +$240K 6.87% 1
2015
Q3 		$13M Buy
162,117
+6,435
+4% +$715K 6.12% 1
2015
Q2 		$18.7M Sell
155,682
-4,350
-3% -$520K 7.41% 1
2015
Q1 		$16.7M Buy
160,032
+850
+0.5% +$86.1K 6.36% 1
2014
Q4 		$15.4M Buy
159,182
+1,650
+1% +$153K 5.98% 1
2014
Q3 		$12.3M Buy
157,532
+5,060
+3% +$326K 4.92% 1
2014
Q2 		$9.63M Buy
152,472
+14,684
+11% +$873K 3.75% 3
2014
Q1 		$9.25M Buy
137,788
+13,230
+11% +$1.02M 3.78% 2
2013
Q4 		$8.01M Buy
124,558
+8,365
+7% +$499K 3.59% 3
2013
Q3 		$7.44M Buy
116,193
+12,975
+13% +$647K 3.78% 1
2013
Q2 		$3.2M Buy
+103,218
New +$2.75M 2.05% 10

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

FIC Capital's ALNY Position: Q3 2017 in Review

FIC Capital reduced its Alnylam Pharmaceuticals (ALNY) stake by 12% in Q3 2017, selling an estimated $1.68M and leaving 150,676 shares worth $17.7M. The position accounts for 6.75% of the portfolio, ranked #2.

FIC Capital first reported a position in ALNY in Q2 2013 and has held it in 18 quarters since. The position peaked at $18.7M in Q2 2015. 235 funds tracked by Wall St. Rank hold ALNY as of Q3 2017.

  • FIC Capital held 150,676 shares of Alnylam Pharmaceuticals worth $17.7M as of Q3 2017.
  • FIC Capital sold 19,653 Alnylam Pharmaceuticals shares in Q3 2017, an estimated $1.68M.
  • Alnylam Pharmaceuticals made up 6.75% of FIC Capital's portfolio in Q3 2017, its #2 holding.
  • FIC Capital first reported a position in Alnylam Pharmaceuticals in Q2 2013 and has held it in 18 quarters since.
  • FIC Capital's Alnylam Pharmaceuticals position peaked at $18.7M in Q2 2015.
  • 235 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2017.

Based on FIC Capital's 13F filing for Q3 2017, filed 14 Nov 2017.